Search

Your search keyword '"Zukotynski K"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Zukotynski K" Remove constraint Author: "Zukotynski K"
142 results on '"Zukotynski K"'

Search Results

2. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

3. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

4. Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial

6. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

8. A PHASE II STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP CHEMOTHERAPY PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA

9. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

10. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

13. Optimizing the SPECT Imaging Workflow For Individualized Dosimetry in Lu177-DOTATATE Treatment Of Progressive Metastatic Neoendocrine Tumors

15. Quantifying Renal And Tumor Doses with Individualized Dosimetry In 177Lu DOTATATE Therapy – What Difference Does It Make?

23. The value of SPECT in the detection of stress injury to the pars interarticularis in patients with low back pain

26. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

27. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

28. Patterns of failure with 18 F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting: A regional cohort analysis.

29. Performance and Interpretation of Lung Scintigraphy: An Evaluation of Current Practices in Australia, Canada, France, Germany, and United States.

30. Wavelet phase coherence of ictal scalp EEG-extracted muscle activity (SMA) as a biomarker for sudden unexpected death in epilepsy (SUDEP).

31. Interreader and Intrareader Reproducibility of 18 F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.

32. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.

33. Role of PET/Computed Tomography in Gastric and Colorectal Malignancies.

34. ACR Appropriateness Criteria® Left Lower Quadrant Pain: 2023 Update.

36. A brief overview of targeted radionuclide therapy trials in 2022.

37. Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.

38. ACR Appropriateness Criteria® Right Upper Quadrant Pain: 2022 Update.

39. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.

40. Ictal ECG-based assessment of sudden unexpected death in epilepsy.

41. 18 F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.

42. Intra-individual comparison of 18 F-sodium fluoride PET-CT and 99m Tc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.

43. ACR Appropriateness Criteria® Right Lower Quadrant Pain: 2022 Update.

45. Effect of 18 F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.

46. A Peri-Ictal EEG-Based Biomarker for Sudden Unexpected Death in Epilepsy (SUDEP) Derived From Brain Network Analysis.

47. PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.

48. Management of Differentiated Thyroid Cancer: The Standard of Care.

49. Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI.

Catalog

Books, media, physical & digital resources